Exogenous surfactant therapy in non-respiratory distress syndrome
There is clinical evidence of the benefit of exogenous surfactant therapy to certain neonates with severe respiratory failure, diaphragmatic hernia, pneumonia and meconium aspiration syndrome. There still remain, however, important unanswered questions regarding, for example, optimum dosage a...
Saved in:
| Main Author: | A Greenough |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
1996-01-01
|
| Series: | The Turkish Journal of Pediatrics |
| Online Access: | https://turkjpediatr.org/article/view/3450 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Exogenous Surfactants on the Parameters of Blood Gas Composition in Neonatal Respiratory Distress Syndrome
by: S. A. Perepelitsa, et al.
Published: (2007-06-01) -
Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond
by: Ozge Sürmeli-Onay, et al.
Published: (2012-06-01) -
Replacement Therapy with the Surfactant Alveofact for Neonatal Respiratory Distress Syndrome: A Pilot Study
by: S. A. Perepelitsa
Published: (2014-08-01) -
Significance of surfactant proteins in respiratory distress syndrome in preterm infants
by: İ.A. Mirzayeva, et al.
Published: (2024-04-01) -
Exogenous surfactant in the late respiratory phase of COVID-19
by: K. G. Shapovalov, et al.
Published: (2021-06-01)